Filing Details
- Accession Number:
- 0000950103-20-020320
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-20 16:41:42
- Reporting Period:
- 2020-10-16
- Accepted Time:
- 2020-10-20 16:41:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642545 | Shockwave Medical Inc. | SWAV | Surgical & Medical Instruments & Apparatus (3841) | 270494101 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1768408 | Antoine Papiernik | C/O Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara CA 95054 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-10-16 | 7,119 | $79.01 | 1,475,506 | No | 4 | S | Indirect | By Sofinnova Capital VII FCPR |
| Common Stock | Disposition | 2020-10-19 | 9,500 | $79.22 | 1,466,006 | No | 4 | S | Indirect | By Sofinnova Capital VII FCPR |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Sofinnova Capital VII FCPR |
| No | 4 | S | Indirect | By Sofinnova Capital VII FCPR |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,701 | Direct |
Footnotes
- Represents shares directly held by Sofinnova Capital VII FCPR. The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova Capital VII FCPR. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $79.00 to $79.19. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $79.00 to $79.63. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Billionaire Hedge Funds
